This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Neurocrine Biosciences, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Lev Alexander Zegelman - Innovator in Neurobiology
Lev Alexander Zegelman is an inventor based in San Diego, CA (US). He is currently associated with Neurocrine Biosciences, Inc., where he contributes to advancements in neurobiology. Although he does not hold any granted patents, his work is significant in the field of medical research.
Latest Patent Applications
Lev Alexander Zegelman has submitted a patent application titled "CRF Receptor Antagonists and Methods of Use." This application details compounds that antagonize corticotropin-releasing factor (CRF) receptors, particularly CRF receptor 1. The application also discusses related preparations, compositions, and methods for treating diseases and disorders that could benefit from these compounds, such as congenital adrenal hyperplasia (CAH).
Conclusion
Lev Alexander Zegelman's contributions to neurobiology through his research and patent applications highlight his role as an innovator in the field. His work aims to address significant medical challenges and improve treatment options for various disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile